May 17, 2020

Microsoft partners with Adaptive Biotechnologies in a new project

Microsoft
Technology
immunology
Adaptive Biotechnologies
Catherine Sturman
2 min
Microsoft
Microsoft has recently announced that it has entered a partnership with biotech company Adaptive Biotechnologies as part of its NExT initiative.

Both c...

Microsoft has recently announced that it has entered a partnership with biotech company Adaptive Biotechnologies as part of its NExT initiative.

Both companies will work in collaboration to develop a new blood screening test to enable medical professionals to diagnose a number of diseases in one sole screening, and improve the ongoing treatment in chronic diseases such as cancer.

Through mapping the genetics of the human immune system, Microsoft will bring machine learning and exceptional cloud technology to the fore, in order to support Adaptive’s immune sequencing and blood diagnostics, gaining increased insight through essential data produced in real-time.

“This announcement comes at a time of inflection in healthcare and biotechnology. We now have the technology to be able to do what we’ve been talking about for the past decade – develop a universal TCR antigen map that presents an opportunity to help patients at an unprecedented scale,” explained Chad Robins, President, CEO and Co-Founder of Adaptive Biotechnologies.

“Some conditions like cancer or autoimmune disorders can be difficult to diagnose, but this universal map of the immune system will enable earlier and more accurate diagnosis of disease, potentially helping physicians to connect the dots to understand the relationship between disease states and eventually lead to a better understanding of overall human health.”

See also

“We are very excited and inspired by our collaboration with Adaptive Biotechnologies, as it clearly advances our mission to use cloud and AI technologies to transform healthcare and improve the lives of people around the world,” explained Peter Lee, Corporate Vice President, AI and Research, at Microsoft.

“This collaboration combines powerful sequencing and artificial intelligence (AI) technologies into a revolutionary new capability, and represents the kind of deep collaborative partnership that we live for.”

“Imagine a world in which an ‘X-Ray of the immune system’ actually exists,” Lee also highlighted in a blog post. “This would open new doors to predictive medicine, as a person’s immunological history is believed to shape their response to new pathogens and treatments in ways that are currently impossible to explore.

The impact on human health of such a universal blood test that reads a person’s exposure and response to disease would be, in a word, transformational.”

Share article

Jun 24, 2021

Jvion launches AI-powered map to tackle mental health crisis

AI
mentalhealth
dataanalytics
PredictiveAnalytics
2 min
Jvion's new interactive map uses AI to predict areas most vulnerable to poor mental health

Clinical AI company Jvion has launched an interactive map  of the US that highlights areas that are most vulnerable to poor mental health. 

The Behavioral Health Vulnerability Map uses Jvion's AI CORE™ software to analyse public data on social determinants of health (SDOH)  and determine the vulnerability of every US Census block group. 

Vulnerability refers to the likelihood that residents will experience issues like self-harm, suicide attempts or overdoses. The map also identifies the most influential social determinants in each region, to show the social and environmental conditions that contribute to mental illness. 

As an example, the map shows that Harrison County in Mississippi has a 50% higher suicide rate than the rest of the state. It also shows a high percentage of individuals in the armed forces at a time when active duty suicides are at a six-year high, along with a high prevalence of coronary artery disease, arthritis, and COPD, all chronic illnesses that are linked to a higher suicide risk.  

The map also shows Harrison County has a high percentage of Vietnamese Americans, who studies suggest have high rates of depression and may be less likely to seek help from mental health professionals. 

The map was built using the same data and analytics that Jvion used to create the COVID Community Vulnerability Map, which was launched towards the start of the pandemic. 

With this new map, Jvion is aiming to tackle the growing mental health crisis in the US. “At a time when so many Americans are struggling with their mental health, we’re proud to offer a tool that can help direct treatment resources to the communities that need it most,” said Dr John Showalter, MD, Jvion’s chief product officer, who led the development of the map. 

“For too long, the healthcare industry has struggled to address social determinants of health, particularly in the context of behavioural health. Our hope is that by surfacing the social and environmental vulnerabilities of America’s communities, we can better coordinate our response to the underlying conditions that impact the health and wellbeing of people everywhere.” 

Share article